Virtual Medicinal Product (VMP) - Octreotide 50micrograms/1ml solution for injection ampoules

Navigation

Name Details

Name Start Date End Date
Name Current Name Octreotide 50micrograms/1ml solution for injection ampoules Start Date 09-06-2004 End Date
Previous Name Previous Name Octreotide 50micrograms/ml injection 1ml ampoules Start Date 13-02-2003 End Date 08-06-2004

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
1.0
UDFS UOM
ml
Unit Dose UOM
ampoule

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Subcutaneous, Intravenous
Form
Solution for injection
Ontology Form/Route
solutioninjection.intravenous, solutioninjection.subcutaneous
Name Basis
rINN - Recommended International Non-proprietary

Codes

ATC Code
H01CB02
BNF Start Date End Date
Current BNF 08030403 Start Date 04-04-2022 End Date
Previous BNF 08030403 Start Date 14-02-2005 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
36030011000001105 29-10-2018
327340009 17-08-2005 28-10-2018
3883811000001105 13-02-2003 16-08-2005

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Octreotide acetate Based on Base Substance Octreotide 50 microgram 1 ml

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
5 ampoule 1487 Part VIIIA Category C